| # | Pathway | Proteins |
|---|
| 1 | Fat digestion and absorption | ENSAPLP00000003561, ENSAPLP00000002020, ENSAPLP00000006507, ENSAPLP00000016339 |
| 2 | Systemic lupus erythematosus | ENSAPLP00000003774, ENSAPLP00000008440, ENSAPLP00000011291, ENSAPLP00000001720, ENSAPLP00000002160, ENSAPLP00000015167 |
| 3 | Amoebiasis | ENSAPLP00000003774, ENSAPLP00000008440, ENSAPLP00000011291, ENSAPLP00000012559, ENSAPLP00000004050, ENSAPLP00000002160, ENSAPLP00000013412 |
| 4 | Dilated cardiomyopathy | ENSAPLP00000003774, ENSAPLP00000012522, ENSAPLP00000011291, ENSAPLP00000002674, ENSAPLP00000012136, ENSAPLP00000003219 |
| 5 | Vitamin digestion and absorption | ENSAPLP00000003561, ENSAPLP00000002020, ENSAPLP00000016339 |
| 6 | Pentose and glucuronate interconversions | ENSAPLP00000008299, ENSAPLP00000005312, ENSAPLP00000005894 |
| 7 | African trypanosomiasis | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000002020 |
| 8 | Asthma | ENSAPLP00000003774, ENSAPLP00000011291 |
| 9 | Tight junction | ENSAPLP00000016318, ENSAPLP00000008440, ENSAPLP00000004699, ENSAPLP00000012466, ENSAPLP00000005955, ENSAPLP00000002160 |
| 10 | Leishmaniasis | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000015167 |
| 11 | Tuberculosis | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000009762, ENSAPLP00000015167, ENSAPLP00000013412 |
| 12 | Allograft rejection | ENSAPLP00000003774, ENSAPLP00000011291 |
| 13 | Staphylococcus aureus infection | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000015167 |
| 14 | Endocytosis | ENSAPLP00000009097, ENSAPLP00000000447, ENSAPLP00000014387, ENSAPLP00000010989, ENSAPLP00000000706, ENSAPLP00000003542, ENSAPLP00000016193, ENSAPLP00000008982, ENSAPLP00000013412 |
| 15 | Intestinal immune network for IgA production | ENSAPLP00000003774, ENSAPLP00000011291 |
| 16 | Primary immunodeficiency | ENSAPLP00000003774, ENSAPLP00000011291 |
| 17 | Autoimmune thyroid disease | ENSAPLP00000003774, ENSAPLP00000011291 |
| 18 | Transcriptional misregulation in cancer | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000013972 |
| 19 | Histidine metabolism | ENSAPLP00000003438, ENSAPLP00000008299 |
| 20 | Glycerolipid metabolism | ENSAPLP00000008299, ENSAPLP00000005894 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ENSAPLP00000012522, ENSAPLP00000008440, ENSAPLP00000002674, ENSAPLP00000002160 |
| 22 | Arginine and proline metabolism | ENSAPLP00000008299, ENSAPLP00000010692, ENSAPLP00000006507 |
| 23 | Hypertrophic cardiomyopathy (HCM) | ENSAPLP00000012522, ENSAPLP00000002674, ENSAPLP00000012136, ENSAPLP00000003219 |
| 24 | Cardiac muscle contraction | ENSAPLP00000002674, ENSAPLP00000012136, ENSAPLP00000003219 |
| 25 | Measles | ENSAPLP00000003774, ENSAPLP00000000447, ENSAPLP00000011291 |
| 26 | Focal adhesion | ENSAPLP00000008440, ENSAPLP00000013787, ENSAPLP00000003837, ENSAPLP00000005411, ENSAPLP00000012559, ENSAPLP00000010427, ENSAPLP00000002160 |
| 27 | Adrenergic signaling in cardiomyocytes | ENSAPLP00000002674, ENSAPLP00000012136, ENSAPLP00000003219, ENSAPLP00000004699 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis | ENSAPLP00000006507 |
| 29 | Proteoglycans in cancer | ENSAPLP00000013972, ENSAPLP00000013787, ENSAPLP00000003837, ENSAPLP00000012559, ENSAPLP00000004826, ENSAPLP00000013792 |
| 30 | Hematopoietic cell lineage | ENSAPLP00000003774, ENSAPLP00000011291 |
| 31 | Bacterial invasion of epithelial cells | ENSAPLP00000009097, ENSAPLP00000000706, ENSAPLP00000012559, ENSAPLP00000010427 |
| 32 | Regulation of actin cytoskeleton | ENSAPLP00000008440, ENSAPLP00000005411, ENSAPLP00000012559, ENSAPLP00000010427, ENSAPLP00000005955, ENSAPLP00000002160 |
| 33 | NF-kappa B signaling pathway | ENSAPLP00000003774, ENSAPLP00000011291 |
| 34 | Legionellosis | ENSAPLP00000000447, ENSAPLP00000015167 |
| 35 | Rheumatoid arthritis | ENSAPLP00000003774, ENSAPLP00000011291 |
| 36 | Complement and coagulation cascades | ENSAPLP00000005849, ENSAPLP00000003063, ENSAPLP00000015167 |
| 37 | Lysine degradation | ENSAPLP00000008299, ENSAPLP00000008955 |
| 38 | MAPK signaling pathway | ENSAPLP00000000447, ENSAPLP00000003837, ENSAPLP00000002674, ENSAPLP00000004050 |
| 39 | Endocrine and other factor-regulated calcium reabsorption | ENSAPLP00000009097, ENSAPLP00000000706 |
| 40 | B cell receptor signaling pathway | ENSAPLP00000003774, ENSAPLP00000011291 |
| 41 | Lysosome | ENSAPLP00000014136, ENSAPLP00000009097, ENSAPLP00000009762, ENSAPLP00000000706 |
| 42 | Calcium signaling pathway | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000005411 |
| 43 | Phagosome | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000015167, ENSAPLP00000013412 |
| 44 | ECM-receptor interaction | ENSAPLP00000013787, ENSAPLP00000012559, ENSAPLP00000004826 |
| 45 | Natural killer cell mediated cytotoxicity | ENSAPLP00000003774, ENSAPLP00000011291 |
| 46 | Fc epsilon RI signaling pathway | ENSAPLP00000003774, ENSAPLP00000011291 |
| 47 | Ether lipid metabolism | ENSAPLP00000015568 |
| 48 | Ascorbate and aldarate metabolism | ENSAPLP00000008299 |
| 49 | Synaptic vesicle cycle | ENSAPLP00000009097, ENSAPLP00000000706 |
| 50 | Viral myocarditis | ENSAPLP00000003774, ENSAPLP00000011291 |
| 51 | Viral carcinogenesis | ENSAPLP00000008440, ENSAPLP00000001720, ENSAPLP00000002160, ENSAPLP00000015167 |
| 52 | PPAR signaling pathway | ENSAPLP00000006229, ENSAPLP00000002020 |
| 53 | PI3K-Akt signaling pathway | ENSAPLP00000003774, ENSAPLP00000011291, ENSAPLP00000013787, ENSAPLP00000012559, ENSAPLP00000004699 |
| 54 | Phenylalanine metabolism | ENSAPLP00000006507 |
| 55 | Prion diseases | ENSAPLP00000000447, ENSAPLP00000009423 |
| 56 | Epstein-Barr virus infection | ENSAPLP00000003774, ENSAPLP00000000447, ENSAPLP00000011291, ENSAPLP00000004050 |
| 57 | Arginine biosynthesis | ENSAPLP00000006507 |
| 58 | Chagas disease (American trypanosomiasis) | ENSAPLP00000004699, ENSAPLP00000015167 |
| 59 | Leukocyte transendothelial migration | ENSAPLP00000008440, ENSAPLP00000013972, ENSAPLP00000002160 |
| 60 | Salmonella infection | ENSAPLP00000003837, ENSAPLP00000005955 |
| 61 | Sphingolipid signaling pathway | ENSAPLP00000009762, ENSAPLP00000004699 |
| 62 | Bladder cancer | ENSAPLP00000013972 |
| 63 | AMPK signaling pathway | ENSAPLP00000004695, ENSAPLP00000004699 |
| 64 | Phospholipase D signaling pathway | ENSAPLP00000003774, ENSAPLP00000011291 |
| 65 | Estrogen signaling pathway | ENSAPLP00000000447, ENSAPLP00000013972 |
| 66 | Drug metabolism - other enzymes | ENSAPLP00000011737 |
| 67 | Valine, leucine and isoleucine degradation | ENSAPLP00000008299, ENSAPLP00000012021 |
| 68 | Fc gamma R-mediated phagocytosis | ENSAPLP00000003774, ENSAPLP00000011291 |
| 69 | Mineral absorption | ENSAPLP00000015679 |
| 70 | 2-Oxocarboxylic acid metabolism (no map in kegg database) | ENSAPLP00000006507 |
| 71 | Ovarian steroidogenesis | ENSAPLP00000010639 |
| 72 | Hepatitis B | ENSAPLP00000013972, ENSAPLP00000004826 |
| 73 | Vascular smooth muscle contraction | ENSAPLP00000005411, ENSAPLP00000005955 |
| 74 | Adherens junction | ENSAPLP00000008440, ENSAPLP00000002160 |
| 75 | Aldosterone synthesis and secretion | ENSAPLP00000010639 |
| 76 | Galactose metabolism | ENSAPLP00000005894 |
| 77 | Tyrosine metabolism | ENSAPLP00000006507 |
| 78 | Fructose and mannose metabolism | ENSAPLP00000005894 |
| 79 | TGF-beta signaling pathway | ENSAPLP00000004699 |
| 80 | Steroid hormone biosynthesis | ENSAPLP00000010639 |
| 81 | Tryptophan metabolism | ENSAPLP00000008299 |
| 82 | beta-Alanine metabolism | ENSAPLP00000008299 |
| 83 | Alanine, aspartate and glutamate metabolism | ENSAPLP00000006507 |
| 84 | Starch and sucrose metabolism | ENSAPLP00000010189 |
| 85 | VEGF signaling pathway | ENSAPLP00000004050 |
| 86 | Oxytocin signaling pathway | ENSAPLP00000005411, ENSAPLP00000002674 |
| 87 | Biosynthesis of amino acids (no map in kegg database) | ENSAPLP00000005312, ENSAPLP00000006507 |
| 88 | GABAergic synapse (no map in kegg database) | ENSAPLP00000003730 |
| 89 | Vasopressin-regulated water reabsorption | ENSAPLP00000013412 |
| 90 | Amyotrophic lateral sclerosis (ALS) | ENSAPLP00000012498 |
| 91 | Pertussis | ENSAPLP00000015167 |
| 92 | Cysteine and methionine metabolism | ENSAPLP00000006507 |
| 93 | MicroRNAs in cancer | ENSAPLP00000013972, ENSAPLP00000003219 |
| 94 | TNF signaling pathway | ENSAPLP00000013972 |
| 95 | Pentose phosphate pathway | ENSAPLP00000005312 |
| 96 | Carbon metabolism (no map in kegg database) | ENSAPLP00000005312, ENSAPLP00000008955, ENSAPLP00000006507 |
| 97 | Hepatitis C | ENSAPLP00000004699 |
| 98 | Ribosome biogenesis in eukaryotes | ENSAPLP00000006775 |
| 99 | Long-term depression | ENSAPLP00000004699 |
| 100 | Antigen processing and presentation | ENSAPLP00000000447 |
| 101 | Gastric acid secretion | ENSAPLP00000005411 |
| 102 | Citrate cycle (TCA cycle) | ENSAPLP00000008955 |
| 103 | Insulin resistance | ENSAPLP00000010189 |
| 104 | Pyruvate metabolism | ENSAPLP00000008299 |
| 105 | Hippo signaling pathway - fly | ENSAPLP00000004699 |
| 106 | Fatty acid degradation | ENSAPLP00000008299 |
| 107 | Cell adhesion molecules (CAMs) | ENSAPLP00000009423 |
| 108 | RNA degradation | ENSAPLP00000006939 |
| 109 | Small cell lung cancer | ENSAPLP00000012559 |
| 110 | Glucagon signaling pathway | ENSAPLP00000010189 |
| 111 | Shigellosis | ENSAPLP00000010427 |
| 112 | Oocyte meiosis | ENSAPLP00000004699 |
| 113 | Glycolysis / Gluconeogenesis | ENSAPLP00000008299 |
| 114 | mRNA surveillance pathway | ENSAPLP00000004699 |
| 115 | Toxoplasmosis | ENSAPLP00000000447 |
| 116 | Hippo signaling pathway | ENSAPLP00000004699 |
| 117 | HIF-1 signaling pathway | ENSAPLP00000015679 |
| 118 | Influenza A | ENSAPLP00000000447 |
| 119 | Ribosome | ENSAPLP00000016149, ENSAPLP00000012889 |
| 120 | Dopaminergic synapse | ENSAPLP00000004699 |
| 121 | Spliceosome | ENSAPLP00000000447, ENSAPLP00000008668 |
| 122 | Alcoholism | ENSAPLP00000001720 |
| 123 | cGMP-PKG signaling pathway | ENSAPLP00000005411 |
| 124 | Huntington's disease | ENSAPLP00000009097, ENSAPLP00000000706 |
| 125 | Insulin signaling pathway | ENSAPLP00000010189 |
| 126 | Herpes simplex infection | ENSAPLP00000015167 |
| 127 | Purine metabolism | ENSAPLP00000008550 |
| 128 | Ras signaling pathway | ENSAPLP00000013412 |
| 129 | Metabolic pathways (no map in kegg database) | ENSAPLP00000011737, ENSAPLP00000008299, ENSAPLP00000005312, ENSAPLP00000005894, ENSAPLP00000008550, ENSAPLP00000010639, ENSAPLP00000012021, ENSAPLP00000010189, ENSAPLP00000008955, ENSAPLP00000010692, ENSAPLP00000006507 |
| 130 | Platelet activation | ENSAPLP00000005411 |
| 131 | Protein processing in endoplasmic reticulum | ENSAPLP00000000447 |
| 132 | Pathways in cancer | ENSAPLP00000013972, ENSAPLP00000012559 |